PERSPECTA

News from every angle

← Back to headlines

Wall Street Skeptical of AstraZeneca and Bristol-Myers Squibb Merger Talks

Reports indicate Wall Street analysts are not convinced by recent discussions regarding a potential merger between AstraZeneca PLC and Bristol-Myers Squibb Company.

11 Aug, 19:34 — 11 Aug, 19:34
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual1d ago

AstraZeneca PLC (AZN) vs. Bristol-Myers Squibb Company (BMY): Wall Street Doesn’t Buy This Merger Talk

Read full article →

Related Stories

Workday Shares Surge on Silver Lake Takeover Report

16m ago

OpenAI Sees Second Executive Departure This Week with Denise Dresser

1h ago

Eagle Point Credit Company Declares Multiple Dividends and Reports Q2 Earnings

1h ago

Large Explosion Reported at Ammunition Factory Near Rome

1h ago